Back to EP Wealth Advisors, LLC EP Wealth Advisors, LLC

ARWR

12 quarters

Position history for EP Wealth Advisors, LLCEP Wealth Advisors, LLC's holdings in Arrowhead Pharmaceuticals, Inc.

Yes. EP Wealth Advisors holds 38,135 shares of ARWR (Arrowhead Pharmaceuticals), worth $3.1M, as of its Q2 2026 13F filing. It reduced the position by 271 shares (-0.7%) from Q1 2026. EP Wealth Advisors has held ARWR since Q2 2025, across 4 quarterly 13F filings.

Current Value

$3.1M

Current Shares

38,135

Total Value Change

+$2.8M

Total Shares Change

+29,635

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
38,135
-0.7%
$3.1M0.0%$81.51
0
2026-Q1
Decreased
38,406
-0.7%
$2.4M0.0%$62.70
0
2025-Q4
Increased
38,683
+0.4%
$2.6M0.0%$66.39
26
2025-Q2
New
38,524
-
$608,6790.0%$15.80
34
2024-Q3
Exited
0
-100.0%
$00.0%$19.37
0
2024-Q2
Increased
8,844
+0.3%
$229,8560.0%$25.99
23
2024-Q1
Increased
8,819
+3.8%
$252,2230.0%$28.60
24
2023-Q4
Unchanged
8,500
0.0%
$260,1000.0%$30.60
0
2023-Q3
Increased
8,500
+851.9%
$228,3950.0%$26.87
37
2023-Q2
Decreased
893
-89.5%
$306,6760.0%$35.66
0
2023-Q1
Unchanged
8,500
0.0%
$215,9000.0%$25.40
0
2022-Q4
New
8,500
-
$344,7600.0%$40.56
33

Other major holders of ARWR: BlackRock, Inc., Vanguard Group Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used